Valuation: Bayer AG

Market Cap 4.76TCr 5.44TCr 4.39TCr 4.05TCr 7.63TCr 5,24400Cr 7.8TCr 53TCr 21TCr 2,56700Cr 20TCr 20TCr 8,84400Cr P/E 2026 *
20.9x
P/E 2027 * 15.7x
Enterprise Value 7.94TCr 9.09TCr 7.33TCr 6.75TCr 13TCr 8,75200Cr 13TCr 88TCr 34TCr 4,28400Cr 34TCr 33TCr 14,75900Cr EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.63x
Free-Float
100%
Yield 2026 *
0.47%
Yield 2027 * 1.3%
1 week-5.74%
Current month+0.88%
1 month+29.90%
3 months+16.61%
6 months+17.35%
Current year+33.38%
1 week 205.3
Extreme 205.3
216
1 month 159.05
Extreme 159.05
230.5
3 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%-5.00%+75.41%-10.02% 5.36TCr
+0.85%-3.11%+49.29%+162.34% 1,04300Cr
+1.23%-2.34%+53.56%+58.28% 60TCr
+0.04%+1.83%+33.53%+87.11% 45TCr
+0.78%-0.39%+30.44%+23.23% 33TCr
+1.41%+0.56%+31.41%+47.13% 28TCr
-0.27%-5.69%+20.68%+21.99% 26TCr
-1.42%+0.73%+22.50%+61.06% 20TCr
-1.48%-0.42%+22.24%+73.96% 17TCr
-0.36%+3.30%+1.79%-31.03% 14TCr
Average -0.09%-0.68%+34.09%+49.40% 38.63TCr
Weighted average by Cap. -0.04%-1.82%+38.37%+82.08%

Financials

2026 *2027 *
Net sales 4.56TCr 5.22TCr 4.21TCr 3.88TCr 7.31TCr 5,02400Cr 7.47TCr 50TCr 20TCr 2,45900Cr 20TCr 19TCr 8,47200Cr 4.68TCr 5.35TCr 4.32TCr 3.98TCr 7.5TCr 5,15000Cr 7.66TCr 52TCr 20TCr 2,52100Cr 20TCr 20TCr 8,68600Cr
Net income 212.62Cr 243.18Cr 196.25Cr 180.77Cr 340.91Cr 23TCr 348.23Cr 2.35TCr 921.67Cr 11TCr 913.21Cr 893.12Cr 39TCr 293.26Cr 335.4Cr 270.68Cr 249.33Cr 470.2Cr 32TCr 480.3Cr 3.24TCr 1.27TCr 16TCr 1.26TCr 1.23TCr 54TCr
Net Debt 3.18TCr 3.64TCr 2.94TCr 2.71TCr 5.11TCr 3,50800Cr 5.22TCr 35TCr 14TCr 1,71700Cr 14TCr 13TCr 5,91500Cr 2.87TCr 3.28TCr 2.65TCr 2.44TCr 4.6TCr 3,16300Cr 4.7TCr 32TCr 12TCr 1,54800Cr 12TCr 12TCr 5,33400Cr
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
17/26/17 PLN 205.30 -0.77%
16/26/16 PLN 206.90 -1.71%
15/26/15 PLN 210.50 -2.55%
14/26/14 PLN 216.00 0.00%
13/26/13 PLN 216.00 -0.83%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.72EUR
Average target price
54.92EUR
Spread / Average Target
+15.08%

Quarterly revenue - Rate of surprise